Log In
BCIQ
Print this Print this
 

IO103

  Manage Alerts
Collapse Summary General Information
Company IO Biotech ApS
DescriptionPeptide vaccine containing an XX-mer PD-L1-derived peptide
Molecular Target Programmed cell death 1 ligand 1 (PD-L1) (B7-H1) (CD274)
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHematologic malignancies
Indication DetailsTreat hematologic malignancies
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today